| Apr 22, 2026 | earnings | Lam Research announced financial results for the fiscal quarter ended March 29, 2026. |
|---|
| Feb 4, 2026 | management_change | Patrick J. Lord, Ph.D. retired, and Seshasayee Varadarajan was appointed EVP and COO. |
|---|
| Feb 3, 2026 | management_change | Lam Research appointed Anirudh Devgan, Ph.D., 56, to its Board of Directors. |
|---|
| Apr 22, 2026 | Guidance: diluted_eps | 1.50 to 1.80 |
|---|
| Apr 22, 2026 | Guidance: diluted_share_count | 1.25 to 1.25 |
|---|
| Apr 22, 2026 | Guidance: gross_margin | 49.50 to 51.50 |
|---|
| Apr 23, 2026 | mda_quarterly | Lam Research (LRCX) faces substantial geopolitical and supply chain risks, significantly impacting its financial performance. International sales comprise 93-94% of total revenue, with China alone accounting for 34-42%. U.S. export controls, particularly those restricting advanced semiconductor technology to China and sales to entities like Huawei, have already reduced revenue and intensified foreign competition, with further adverse effects anticipated. Geopolitical instability, such as the Middle East conflict, also threatens critical commodity supplies (e.g., aluminum, helium) vital for semiconductor manufacturing.
The company's supply chain is vulnerable to disruptions from reliance on single or limited suppliers, long lead times, and volatile material costs driven by tariffs, inflation, and export controls (e.g., China's rare earth elements). Emerging regulations, such as potential PFAS restrictions, could further impact material availability and costs. LRCX's revenue concentration in a limited number of high-value products makes it susceptible to demand shifts or competitive pressures. Financially, LRCX carries $3.75 billion in senior unsecured notes. The company actively manages capital through share repurchases, including a $10 billion authorization and recent accelerated share repurchase agreements totaling $700 million (March 2026 and April 2025), subject to a 1% excise tax. Foreign currency exposure is primarily hedged for Japanese yen revenues and expenses in euro, Korean won, Malaysian ringgit, and Indian rupee. |
|---|
| Jan 29, 2026 | mda_quarterly | Lam Research Corporation's international sales, particularly to China, which constituted 39% of revenue for the six months ended December 28, 2025, present significant geopolitical risks. U.S. export controls, tariffs, and trade disputes, especially concerning advanced semiconductor technology to China, have already limited market access and could further weaken competitiveness, potentially causing customers to reconsider reliance on LRCX products. Supply chain disruptions are a critical concern due to reliance on single or limited suppliers for key components, long lead times, and potential impacts from PFAS chemical regulations, leading to increased costs, delivery delays, and inability to meet customer demand. The company faces product concentration risk, deriving substantial revenue from a limited number of high-value systems, making it vulnerable to demand shifts or competitive pressures. Financial risks include exposure to foreign currency fluctuations (JPY revenue; EUR, KRW, MYR, INR expenses), potential goodwill or long-lived asset impairments, and leverage from $4.5 billion in senior unsecured notes. LRCX actively returned capital, repurchasing approximately 5.5 million shares for $500 million via Accelerated Share Repurchase agreements in April 2025 at a weighted-average price of $91.00, with $5.085 billion remaining under the share repurchase program as of December 28, 2025. |
|---|
